WO2007009638A3 - Perfluoralkylhaltige komplexe, verfahren zu deren herstellung sowie deren verwendung - Google Patents

Perfluoralkylhaltige komplexe, verfahren zu deren herstellung sowie deren verwendung Download PDF

Info

Publication number
WO2007009638A3
WO2007009638A3 PCT/EP2006/006777 EP2006006777W WO2007009638A3 WO 2007009638 A3 WO2007009638 A3 WO 2007009638A3 EP 2006006777 W EP2006006777 W EP 2006006777W WO 2007009638 A3 WO2007009638 A3 WO 2007009638A3
Authority
WO
WIPO (PCT)
Prior art keywords
production
complexes containing
containing perfluoroalkyl
field
perfluoroalky
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2006/006777
Other languages
English (en)
French (fr)
Other versions
WO2007009638A2 (de
Inventor
Heiko Schirmer
Hanns-Joachim Weinmann
Johannes Platzek
Ludwig Zorn
Bernd Misselwitz
Joerg Meding
Heribert Schmitt-Willich
Thomas Brumby
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Epix Pharmaceuticals Inc
Original Assignee
Schering AG
Epix Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG, Epix Pharmaceuticals Inc filed Critical Schering AG
Priority to EP06791535A priority Critical patent/EP1904463A2/de
Priority to CA002615443A priority patent/CA2615443A1/en
Priority to AU2006272025A priority patent/AU2006272025A1/en
Priority to BRPI0613407-6A priority patent/BRPI0613407A2/pt
Priority to JP2008520780A priority patent/JP2009501174A/ja
Publication of WO2007009638A2 publication Critical patent/WO2007009638A2/de
Publication of WO2007009638A3 publication Critical patent/WO2007009638A3/de
Priority to IL187926A priority patent/IL187926A0/en
Priority to TNP2008000016A priority patent/TNSN08016A1/en
Anticipated expiration legal-status Critical
Priority to NO20080813A priority patent/NO20080813L/no
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Die Erfindung betrifft die in den Patentansprüchen gekennzeichneten Gegenstände, nämlich perfluoralkylhaltige Metallkomplexe mit stickstoffhaltigen Resten der allgemeinen Formel I, Verfahren zu deren Herstellung und ihre Verwendung in der NMR- und Röntgendiagnostik, Radiodiagnostik und Radiotherapie, sowie in der MRT-Lymphographie und zum blood pool imaging.
PCT/EP2006/006777 2005-07-15 2006-07-11 Perfluoralkylhaltige komplexe, verfahren zu deren herstellung sowie deren verwendung Ceased WO2007009638A2 (de)

Priority Applications (8)

Application Number Priority Date Filing Date Title
EP06791535A EP1904463A2 (de) 2005-07-15 2006-07-11 Perfluoralkylhaltige komplexe, verfahren zu deren herstellung sowie deren verwendung
CA002615443A CA2615443A1 (en) 2005-07-15 2006-07-11 Perfluoroalkyl-containing complexes, process for their production as well as their use
AU2006272025A AU2006272025A1 (en) 2005-07-15 2006-07-11 Complexes containing perfluoroalkyl, method for the production and use thereof
BRPI0613407-6A BRPI0613407A2 (pt) 2005-07-15 2006-07-11 Complexos contendo perfluoralquila, bem como composição farmacêutica, uso e processos de preparação dos mesmos
JP2008520780A JP2009501174A (ja) 2005-07-15 2006-07-11 ペルフルオロアルキル含有錯体、製造方法およびその使用
IL187926A IL187926A0 (en) 2005-07-15 2007-12-06 Complexes containing perfluoroalkyl, method for the production and use thereof
TNP2008000016A TNSN08016A1 (en) 2005-07-15 2008-01-14 Complexes containing perfluoroalkyl, method for the production and use thereof
NO20080813A NO20080813L (no) 2005-07-15 2008-02-14 Komplekser inneholdende perfluoralkyl, fremgangsmate for fremstilling og anvendelse derav

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005033902.6 2005-07-15
DE102005033902A DE102005033902B3 (de) 2005-07-15 2005-07-15 Perfluoralkylhaltige Komplexe, Verfahren zu deren Herstellung, sowie deren Verwendung und diese enthaltende pharmazeutische Mittel

Publications (2)

Publication Number Publication Date
WO2007009638A2 WO2007009638A2 (de) 2007-01-25
WO2007009638A3 true WO2007009638A3 (de) 2007-04-26

Family

ID=37057146

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/006777 Ceased WO2007009638A2 (de) 2005-07-15 2006-07-11 Perfluoralkylhaltige komplexe, verfahren zu deren herstellung sowie deren verwendung

Country Status (22)

Country Link
EP (1) EP1904463A2 (de)
JP (1) JP2009501174A (de)
KR (1) KR20080043762A (de)
CN (1) CN101223148A (de)
AR (1) AR054865A1 (de)
AU (1) AU2006272025A1 (de)
BR (1) BRPI0613407A2 (de)
CA (1) CA2615443A1 (de)
CR (1) CR9645A (de)
DE (1) DE102005033902B3 (de)
DO (1) DOP2006000167A (de)
EC (1) ECSP088100A (de)
GT (1) GT200600313A (de)
IL (1) IL187926A0 (de)
NO (1) NO20080813L (de)
PE (1) PE20070376A1 (de)
RU (1) RU2008105356A (de)
TN (1) TNSN08016A1 (de)
TW (1) TW200706538A (de)
UY (1) UY29664A1 (de)
WO (1) WO2007009638A2 (de)
ZA (1) ZA200801523B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007015598A1 (de) * 2007-03-29 2008-10-02 Heinrich-Heine-Universität Düsseldorf Verwendung von fluorhaltigen Verbindungen zu Diagnosezwecken mit Hilfe bildgebender Verfahren
JP5730581B2 (ja) 2008-01-08 2015-06-10 ランセウス メディカル イメージング， インコーポレイテッド 造影剤としてのｎ−アルコキシアミド抱合体
WO2021067738A1 (en) * 2019-10-04 2021-04-08 United States Government As Represented By The Department Of Veterans Affairs Development of imaging and therapeutic glucose analogues for sodium dependent glucose transporters
EP4059925A1 (de) 2021-03-15 2022-09-21 Bayer Aktiengesellschaft Neues kontrastmittel zur verwendung in der magnetresonanzbildgebung
CN114181164A (zh) * 2021-12-13 2022-03-15 武汉大学中南医院 基于Fe(Ⅱ)特异性MRI对比剂的合成方法及其应用
EP4335462A1 (de) 2022-09-09 2024-03-13 Bayer AG Kontrastmittel zur verwendung in der diagnostischen bildgebung mittels computertomografie
EP4335840A1 (de) 2022-09-09 2024-03-13 Bayer Aktiengesellschaft Neue kontrastmittel zur verwendung in der diagnostischen bildgebung

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19914101C1 (de) * 1999-03-22 2000-10-12 Schering Ag Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik
WO2002013875A2 (de) * 2000-08-11 2002-02-21 Schering Aktiengesellschaft Perfluoralkylhaltige komplexe mit polaren resten, verfahren zu deren herstellung und ihre verwendung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4317588C2 (de) * 1993-05-24 1998-04-16 Schering Ag Fluorhaltige makrocyclische Metallkomplexe, Verfahren zu ihrer Herstellung, sowie ihre Verwendung
DE19603033A1 (de) * 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19744004C1 (de) * 1997-09-26 1999-07-22 Schering Ag Lipophile Metall-Komplexe für Nekrose und Infarkt-Imaging
DE19744003B4 (de) * 1997-09-26 2004-07-08 Schering Ag Kontrastmittel für das Infarkt- und Nekroseimaging

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19914101C1 (de) * 1999-03-22 2000-10-12 Schering Ag Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik
WO2002013875A2 (de) * 2000-08-11 2002-02-21 Schering Aktiengesellschaft Perfluoralkylhaltige komplexe mit polaren resten, verfahren zu deren herstellung und ihre verwendung

Also Published As

Publication number Publication date
AU2006272025A1 (en) 2007-01-25
TW200706538A (en) 2007-02-16
DOP2006000167A (es) 2007-02-28
GT200600313A (es) 2007-04-23
EP1904463A2 (de) 2008-04-02
AR054865A1 (es) 2007-07-25
CR9645A (es) 2008-05-21
ZA200801523B (en) 2008-11-26
PE20070376A1 (es) 2007-04-20
KR20080043762A (ko) 2008-05-19
UY29664A1 (es) 2007-02-28
BRPI0613407A2 (pt) 2011-01-11
ECSP088100A (es) 2008-05-30
NO20080813L (no) 2008-04-09
TNSN08016A1 (en) 2009-07-14
JP2009501174A (ja) 2009-01-15
RU2008105356A (ru) 2009-08-20
CA2615443A1 (en) 2007-01-25
DE102005033902B3 (de) 2007-04-05
CN101223148A (zh) 2008-07-16
WO2007009638A2 (de) 2007-01-25
IL187926A0 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
TNSN08016A1 (en) Complexes containing perfluoroalkyl, method for the production and use thereof
WO2007002109A3 (en) Multidentate pyrone-derived chelators for medicinal imaging and chelation
AU2003302229A8 (en) Imaging by magnetic resonance adsorption, elastography and tomography
WO2017019184A3 (en) Method and apparatus for removing motion artifacts from biomedical signals
IL202487A (en) Annals of 5,5 '- (hydroxyalkyl-diethyl) bis (formylazandyl) bis (2,4,6-triiodophenyl preserved), a diagnostic factor containing them and methods of diagnosis and imaging containing these factors
BRPI0617151B8 (pt) composto, multímero, composto vetorizado, complexo do referido composto, bem como composições farmacêutica, farmacêutica lipídica e de diagnóstico para imagiologia por ressonância magnética e processo para a preparação de um complexo metálico
IS4790A (is) Málmsamstæður sem innihalda Perflúoróalkýl og notkun þeirra við segulsneiðmyndunar-greiningar
IL180896A0 (en) Method of tumour imaging
WO2008082657A3 (en) Mri imageable liposomes for the evaluation of treatment efficacy, thermal distribution. and demonstration of dose painting
RU2007131930A (ru) Лечение и диагностика заболеваний, опосредованных макрофагами
WO2007009637A3 (de) Deren verwendung als kontrastmittel zur anwendung in der nmr-, rontgen- und radiodiagnostik sowie in der radiotheraphie
WO2004112839A3 (en) Specific high-relaxivity conjugate compounds for magnetic resonance imaging
MX2007001035A (es) Metodo para producir una composicion, la composicion y su uso.
ATE361299T1 (de) Oligomere der gadolinium chelate, ihre verwendung als nmr-kontrastmittel und zwischenverbindungen
EP2098522A4 (de) Neue verbindung mit affinität zu amyloid
EA200700202A1 (ru) Гетероарильные соединения в качестве бетамиметиков для лечения заболеваний дыхательных путей
DE602006008135D1 (de) Metallchelate von makrocyclischen polyaminocarbonsäurederivaten und deren anwendung bei der diagnostischen bilderzeugung
WO2003088823A3 (en) Novel macrocyclic activatible magnetic resonance imaging contrast agents
EP4512815A3 (de) Manganchelatisomere
SG151073A1 (en) Contrast agent for use in imaging methods
GB0305422D0 (en) Detection, monitoring and treatment of cancer
PL374027A1 (pl) Zastosowanie zawierających grupy perfluoroalkilowe kompleksów metali jako środków kontrastowych w obrazowaniu metodą rezonansu magnetycznego wewnątrznaczyniowych skrzeplin
AU2003245351A8 (en) Magnetic resonance imaging of metal concentrations
WO2017066070A3 (en) Acetate complexes and methods for acetate quantification
WO2008025941A3 (en) Compounds for imaging and therapy

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006791535

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 187926

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 9453/DELNP/2007

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: DZP2007000804

Country of ref document: DZ

WWE Wipo information: entry into national phase

Ref document number: MX/a/2008/000352

Country of ref document: MX

Ref document number: MX/A/2008/000352

Country of ref document: MX

Ref document number: CR2008-009645

Country of ref document: CR

WWW Wipo information: withdrawn in national office

Ref document number: CR2008-009645

Country of ref document: CR

WWE Wipo information: entry into national phase

Ref document number: 564967

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2008010068

Country of ref document: EG

Ref document number: 12008500102

Country of ref document: PH

Ref document number: 08002702

Country of ref document: CO

Ref document number: 1020087001084

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 200680025890.5

Country of ref document: CN

Ref document number: 2615443

Country of ref document: CA

Ref document number: 2008520780

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2008105356

Country of ref document: RU

Ref document number: 2006272025

Country of ref document: AU

Ref document number: A20080163

Country of ref document: BY

ENP Entry into the national phase

Ref document number: 2006272025

Country of ref document: AU

Date of ref document: 20060711

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2006272025

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2006791535

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: CR2008-009645

Country of ref document: CR

ENP Entry into the national phase

Ref document number: PI0613407

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20080115